Literature DB >> 23097068

Incidence and trends of heart failure admissions after coronary artery bypass grafting surgery.

Abel E Moreyra1, Yingzi Deng, Alan C Wilson, Nora M Cosgrove, William J Kostis, John B Kostis.   

Abstract

AIMS: Factors related to hospitalization for heart failure (HF) following coronary artery bypass grafting (CABG) surgery were studied. METHODS AND
RESULTS: Patients (n = 65 377) undergoing CABG surgery in New Jersey from 1998 to 2007 were identified from the state cardiac surgery database; subsequent hospitalizations for HF were assessed using the Myocardial Infarction Data Acquisition System database. Patients were classified based on pre-operative ejection fraction (EF). Multivariate models were used to identify factors related to HF admission and mortality. Post-CABG HF admission rates among patients with pre-operative EF <35% increased over the 10-year period (P = 0.02), but no significant trend was seen among patients with EF ≥35%. Independent factors associated with post-CABG HF admission within 2 years were: EF, age, female gender, Black race, smoking, diabetes, renal disease, hypertension, and cerebrovascular disease. Pre-operative use of beta-blockers increased over the years (P < 0.0001) and reduced the risk of admission for HF by 13%, with greater benefit in patients with lower EF. Mortality remained unchanged from 1998 to 2007, averaging 1.8% in-hospital and 5.1% and 7.2% at 1-year and 2-year follow-up, respectively.
CONCLUSIONS: Pre-operative EF is a strong predictor of HF admission within 2 years after CABG surgery. The use of beta-blockers decreased HF admission after CABG, especially in patients with EF <35%. Despite the more pronounced benefit and increasing use of beta-blockers in patients with a low EF, HF admission rates in this group of patients are rising. This suggests that more comprehensive management of factors associated with HF is necessary.

Entities:  

Mesh:

Year:  2012        PMID: 23097068     DOI: 10.1093/eurjhf/hfs154

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  8 in total

1.  Feasibility, efficacy, and safety of a simple insulin infusion protocol in a large volume cardiac surgery unit in India.

Authors:  Beena Bansal; Ambrish Mithal; Pravin Carvalho; Yatin Mehta; Naresh Trehan
Journal:  Indian J Endocrinol Metab       Date:  2015 Jan-Feb

2.  Recovery free of heart failure after acute coronary syndrome and coronary revascularization.

Authors:  Alec Falkenham; Manoj K Saraswat; Chloe Wong; Kareem Gawdat; Tanya Myers; Jahanara Begum; Karen J Buth; Ian Haidl; Jean Marshall; Jean-Francois Légaré
Journal:  ESC Heart Fail       Date:  2017-07-24

3.  Quality of medical therapy in heart failure patients undergoing elective revascularisation: A protective effect of disease modifying therapy at discharge.

Authors:  Raphael Wurm; Martin Huelsmann; Marius Hienert; Veronika Seidl; Dominik Wiedemann; Guenther Laufer; Alfred Kocher; Christopher Adlbrecht; Martin Andreas
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

Review 4.  Management of patients after coronary artery bypass grafting surgery: a guide for primary care practitioners.

Authors:  Dominique de Waard; Andrew Fagan; Christo Minnaar; David Horne
Journal:  CMAJ       Date:  2021-05-10       Impact factor: 8.262

5.  Sleep apnea and recurrent heart failure hospitalizations after coronary artery bypass grafting.

Authors:  Yao Hao Teo; Wilson W Tam; Chieh-Yang Koo; Aye-Thandar Aung; Ching-Hui Sia; Raymond C C Wong; William Kong; Kian-Keong Poh; Theodoros Kofidis; Pipin Kojodjojo; Chi-Hang Lee
Journal:  J Clin Sleep Med       Date:  2021-12-01       Impact factor: 4.062

Review 6. 

Authors:  Dominique de Waard; Andrew Fagan; Christo Minnaar; David Horne
Journal:  CMAJ       Date:  2021-07-19       Impact factor: 8.262

7.  Empagliflozin reduces cardiovascular events, mortality and renal events in participants with type 2 diabetes after coronary artery bypass graft surgery: subanalysis of the EMPA-REG OUTCOME® randomised trial.

Authors:  Subodh Verma; C David Mazer; David Fitchett; Silvio E Inzucchi; Egon Pfarr; Jyothis T George; Bernard Zinman
Journal:  Diabetologia       Date:  2018-05-19       Impact factor: 10.122

8.  Risk of Heart Failure in Patients with ST-Elevation Myocardial Infarction Receiving Drug-Eluting Stent Implantation and Undefined Duration of Antiplatelets.

Authors:  Li-Nien Chien; Chun-Chao Chen; Ya-Hui Chang; Fa-Chang Yu; Chen-Ting Tsai; Hung-Yi Liu; Hung-I Yeh; Chao-Feng Lin
Journal:  J Pers Med       Date:  2022-02-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.